Galm O - Search Results

1

Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis.

Veeck J, Niederacher D, An H, Klopocki E, Wiesmann F, Betz B, Galm O, Camara O, Dürst M, Kristiansen G, Huszka C, Knüchel R, Dahl E. Veeck J, et al. Among authors: galm o. Oncogene. 2006 Jun 8;25(24):3479-88. doi: 10.1038/sj.onc.1209386. Epub 2006 Jan 30. Oncogene. 2006. PMID: 16449975

2

Frequent loss of endothelin-3 (EDN3) expression due to epigenetic inactivation in human breast cancer.

Wiesmann F, Veeck J, Galm O, Hartmann A, Esteller M, Knüchel R, Dahl E. Wiesmann F, et al. Among authors: galm o. Breast Cancer Res. 2009;11(3):R34. doi: 10.1186/bcr2319. Epub 2009 Jun 15. Breast Cancer Res. 2009. PMID: 19527488 Free PMC article.

3

Promoter methylation-associated loss of ID4 expression is a marker of tumour recurrence in human breast cancer.

Noetzel E, Veeck J, Niederacher D, Galm O, Horn F, Hartmann A, Knüchel R, Dahl E. Noetzel E, et al. Among authors: galm o. BMC Cancer. 2008 May 30;8:154. doi: 10.1186/1471-2407-8-154. BMC Cancer. 2008. PMID: 18513385 Free PMC article.

4

Epigenetic alterations complement mutation of JAK2 tyrosine kinase in patients with BCR/ABL-negative myeloproliferative disorders.

Jost E, do O N, Dahl E, Maintz CE, Jousten P, Habets L, Wilop S, Herman JG, Osieka R, Galm O. Jost E, et al. Among authors: galm o. Leukemia. 2007 Mar;21(3):505-10. doi: 10.1038/sj.leu.2404513. Epub 2007 Jan 18. Leukemia. 2007. PMID: 17230231

5

Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia.

Galm O, Wilop S, Lüders C, Jost E, Gehbauer G, Herman JG, Osieka R. Galm O, et al. Ann Hematol. 2005 Dec;84 Suppl 1:39-46. doi: 10.1007/s00277-005-0005-0. Ann Hematol. 2005. PMID: 16231140

6

DNA methylation changes in multiple myeloma.

Galm O, Wilop S, Reichelt J, Jost E, Gehbauer G, Herman JG, Osieka R. Galm O, et al. Leukemia. 2004 Oct;18(10):1687-92. doi: 10.1038/sj.leu.2403434. Leukemia. 2004. PMID: 15318245

7

Methylation-associated dysregulation of the suppressor of cytokine signaling-3 gene in multiple myeloma.

Wilop S, van Gemmeren TB, Lentjes MH, van Engeland M, Herman JG, Brümmendorf TH, Jost E, Galm O. Wilop S, et al. Among authors: galm o. Epigenetics. 2011 Aug;6(8):1047-52. doi: 10.4161/epi.6.8.16167. Epub 2011 Aug 1. Epigenetics. 2011. PMID: 21934357 Free article.

8

Aberrant DNA methylation of the transcription factor C/EBPalpha in acute myelogenous leukemia.

Jost E, do O N, Wilop S, Herman JG, Osieka R, Galm O. Jost E, et al. Among authors: galm o. Leuk Res. 2009 Mar;33(3):443-9. doi: 10.1016/j.leukres.2008.07.027. Epub 2008 Aug 30. Leuk Res. 2009. PMID: 18757096

9

CpG island methylation patterns in chronic lymphocytic leukemia.

Seeliger B, Wilop S, Osieka R, Galm O, Jost E. Seeliger B, et al. Among authors: galm o. Leuk Lymphoma. 2009 Mar;50(3):419-26. doi: 10.1080/10428190902756594. Leuk Lymphoma. 2009. PMID: 19347729

10

A systematic comparison of quantitative high-resolution DNA methylation analysis and methylation-specific PCR.

Claus R, Wilop S, Hielscher T, Sonnet M, Dahl E, Galm O, Jost E, Plass C. Claus R, et al. Among authors: galm o. Epigenetics. 2012 Jul;7(7):772-80. doi: 10.4161/epi.20299. Epub 2012 Jul 1. Epigenetics. 2012. PMID: 22647397 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters